Debug Stats | ### Total Build Time: 23 ms 34.950 KB CONCEPT_NAME gt=3 ms Completed: 3 ms rowSize= 354 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 310 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 14 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=0 Completed: 0 ms rowSize= 7 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=0 Completed: 0 ms rowSize= 15 bytesCONCEPT_RELATIONSHIPS gt=9 ms Completed: 9 ms rowSize= 15.324 KBCONCEPT_GENES gt=8 ms Completed: 8 ms rowSize= 17.745 KBCONCEPT_XREFS gt=2 ms Completed: 2 ms rowSize= 1.162 KBCONCEPT_ANCILLARY gt=1 ms Completed: 1 ms rowSize= 14 bytes- Reload Stats
|
Relationships (39)
Relation Types: diso_to_anat : 16 diso_to_diso : 22 diso_to_phen : 1
Relationships: is_abnormal_cell_of_disease : 6 is_associated_anatomic_site_of : 1 is_finding_of_disease : 4 is_normal_cell_origin_of_disease : 4 is_normal_tissue_origin_of_disease : 2 is_not_finding_of_disease : 3 is_primary_anatomic_site_of_disease : 1 isa : 2 location_of : 1 may_be_abnormal_cell_of_disease : 1 may_be_cytogenetic_abnormality_of_disease : 8 may_be_finding_of_disease : 5 permuted_term_of : 1 | |
DISO_to_ANAT | | location_of |
Brain C0006104 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Cancer Cell C0334227 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Cell, Neuroepithelial C1449624 | DISO_to_ANAT | | is_associated_anatomic_site_of |
Central Nervous System C0927232 | DISO_to_ANAT | | may_be_abnormal_cell_of_disease |
Giant Cell, Neoplastic Multinucleated C1514030 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Neoplastic Cell C0597032 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Neoplastic Glial Cell C1513978 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Neoplastic Neuroepithelial Cell C1514048 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Neoplastic Neuroepithelial Cell and Neoplastic Perineural Cell C1514049 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Neoplastic Oligodendrocyte C1514053 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Nerve Cell, Neuroepithelial Cell, and Supporting Cell of the Nervous System C1518293 | DISO_to_ANAT | | is_normal_tissue_origin_of_disease |
Nerve Tissue, Neuroepithelial Tissue, and Nerve Sheaths C1518250 | DISO_to_ANAT | | is_primary_anatomic_site_of_disease |
Nervous System C0027763 | DISO_to_ANAT | | is_normal_tissue_origin_of_disease |
Neuroepithelial Tissue C1518281 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Neuroglia C0027836 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Oligodendrocyte C0028944 | DISO_to_DISO | | isa |
Adult Undifferentiated Oligodendroglioma C0280790 | DISO_to_DISO | | is_finding_of_disease |
Anaplasia C0002793 | DISO_to_DISO | | isa |
Anaplastic Childhood Oligodendroglioma C1332943 | DISO_to_DISO | | permuted_term_of |
Anaplastic Oligodendroglioma C0334590 | DISO_to_DISO | | may_be_cytogenetic_abnormality_of_disease |
CDKN2A Gene Deletion C0805508 | DISO_to_DISO | | may_be_cytogenetic_abnormality_of_disease |
Double Minutes C1512047 | DISO_to_DISO | | may_be_finding_of_disease |
Extensive Necrosis C1517029 | DISO_to_DISO | | may_be_cytogenetic_abnormality_of_disease |
Gain of Chromosome 7 C1517417 | DISO_to_DISO | | may_be_finding_of_disease |
Headache C0018681 |
|
Genes (11)
Species: human : 11 | |
Human | OLIG2 | 10215 | oligodendrocyte lineage transcription factor 2 | The semiquantitative RT-PCR revealed that high levels of expression of Olig1 and Olig2 mRNAs were present in anaplastic oligodendrogliomas and anaplastic astrocytomas, while expression of these mRNAs in grade IV glioblastomas was lower than in grade II and grade III gliomas (p < 0.01). Therefore, although OLIG2 expression was detected in a range of gliomas not specific for oligodendrogliomas, the expression level in anaplastic oligodendrogliomas was more uniform and intense than that in other glial tumors. Immunohistochemical analyses demonstrated that the mean immunopositive proportion of OLIG2 was 82% in anaplastic oligodendrogliomas but only 34% in anaplastic astrocytomas. Immunohistochemistry and microarray analyses demonstrate higher OLIG2 in anaplastic oligodendrogliomas versus glioblastomas, which are heterogeneous with respect to OLIG2 levels. (2001) Lancet 358:298-300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development ( E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. | Human | TCF12 | 6938 | transcription factor 12 | (2001) Lancet 358:298-300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development ( E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. | Human | TCF3 | 6929 | transcription factor 3 | (2001) Lancet 358:298-300]. We investigated the mRNA expression of OLIG1 and OLIG2, as well as four other genes involved in oligodendrocyte development ( E2A, HEB, NKX2.2, and PDGFRA) in a panel of 70 gliomas, including 9 oligodendrogliomas, 11 anaplastic oligodendrogliomas, 5 oligoastrocytomas, 10 anaplastic oligoastrocytomas, 10 diffuse astrocytomas, 10 anaplastic astrocytomas, and 15 glioblastomas. | Human | SOX2 | 6657 | SRY (sex determining region Y)-box 2 | SOX2 mRNA was expressed in ES cells, fetal brain, anaplastic oligodendroglioma, rhabdomyosarcoma, and small cell lung carcinoma. | Human | PIK3CA | 5290 | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Mutations of PIK3CA is associated with anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas | Human | MDM4 | 4194 | Mdm4 p53 binding protein homolog (mouse) | We investigated a series of 208 gliomas (106 glioblastomas, 46 anaplastic gliomas, and 56 low-grade gliomas) and identified 5 tumors (4 glioblastomas and 1 anaplastic oligodendroglioma) with MDM4 amplification and overexpression. | Human | STMN1 | 3925 | stathmin 1 | Loss of heterozygosity for the stathmin gene may be associated with improved outcomes of patients with chromosome 1 anaplastic oligodendroglioma tumors | Human | IGFBP2 | 3485 | insulin-like growth factor binding protein 2, 36kDa | We carried out a gene expression profiling study using cDNA array technology with 24 primary glioma tissues of low-grade (oligodendroglioma), intermediate-grade (anaplastic oligodendroglioma and anaplastic astrocytoma), and high-grade (glioblastomas multiforme) tumors and found that insulin-like growth factor binding protein 2 (IGFBP2) was consistently overexpressed only in glioblastoma multiforme. | Human | GSTP1 | 2950 | glutathione S-transferase pi 1 | GSTP1 and GSTM1 polymorphisms have a role in survival from anaplastic astrocytoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma | Human | GSTM1 | 2944 | glutathione S-transferase mu 1 | GSTP1 and GSTM1 polymorphisms have a role in survival from anaplastic astrocytoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma | Human | CDKN2C | 1031 | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas. We found 1 recurrent anaplastic oligodendroglioma that carried a somatic CDKN2C mutation at codon 113 (GAA ==> TAA: Glu ==> Stop). A p18 mutation was found at an recurrence of an anaplastic oligodendroglioma, but not in the primary, low-grade tumor. |
|